Citation Impact

56 standout
Sub-graph 1 of 22

Citing Papers

ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
2024 Standout
Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections
2024 Standout
6 intermediate papers

Works of Fidi Koppel being referenced

Piperacillin–tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen)
2021
Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis
2016

Author Peers

Author AMB Clinical Biochemistry Pharmacology Molecular Medicine Epidemiology Last Decade Papers Cites
Fidi Koppel 57 31 107 146 73 6 189
Fangda Cui 1 27 373
J.A. Skidmore 52 829
Heinrich Meier 1 86 1 12 21 573
Helle M. Sickmann 45 30 31 19 1.1k
Essam Girgawy 36 62 47 18 345 9 547

All Works

Loading papers...

Rankless by CCL
2026